Ovarian Cancer Drug Shows Eye and Nerve Risks in Large Real-World Study
A large real-world analysis of TriNetX health records finds that mirvetuximab soravtansine carries elevated risks of corneal toxicity and peripheral ...
A large real-world analysis of TriNetX health records finds that mirvetuximab soravtansine carries elevated risks of corneal toxicity and peripheral ...
A large real-world study finds once-weekly semaglutide outperforms sulfonylureas, DPP4 inhibitors, and thiazolidinediones on blood sugar, weight, blood pressure, and ...
A study of more than 5,000 US patients with HR-positive/HER2-negative metastatic breast cancer found median survival of only 13.5 months ...
A real-world surveillance study of 259 Taiwanese adults with obesity found that liraglutide produced clinically significant weight loss and a ...
A real-world study of 77 advanced Parkinson's patients finds that neuropsychiatric side effects of foslevodopa/foscarbidopa infusion occur more often than ...
A large real-world study found that adults with type 2 diabetes and atherosclerotic cardiovascular disease who started oral semaglutide had ...
A University of Minnesota study found that a hybrid open-source OCR pipeline extracted Oncotype DX breast cancer recurrence scores from ...
A six-month real-world study in Brazil found that standard multidisciplinary care produced small reductions in children's BMI z-scores while caregivers' ...
The first prospective real-world study of its kind found that most Parkinson's disease patients with uncontrolled motor fluctuations remained on ...
A real-world study of 28 patients found that Nefecon reduced proteinuria by 55.8 percent and improved kidney function in IgA ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine